questionText: To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential economic impact of seeking unlicensed products as an alternative to Creon to mitigate ongoing pancreatic enzyme replacement therapy shortages on pharmac
heading: Pancreatic Enzyme Replacement Therapy: Shortages